Comparison of the Effects of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation in Patients With Prior Non-ST-segment Acute Coronary Syndrome

Trial Profile

Comparison of the Effects of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation in Patients With Prior Non-ST-segment Acute Coronary Syndrome

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.
    • 18 May 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
    • 12 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top